Selva E, Beretta G, Montanini N, Saddler G S, Gastaldo L, Ferrari P, Lorenzetti R, Landini P, Ripamonti F, Goldstein B P
MMDRI, Lepetit Research Center, Gerenzano, Varese.
J Antibiot (Tokyo). 1991 Jul;44(7):693-701. doi: 10.7164/antibiotics.44.693.
A novel antibiotic, GE2270 A, was isolated from the fermentation broth of a strain of Planobispora rosea. The product was found to inhibit bacterial protein synthesis. Structural characteristics showed similarities between GE2270 A and thiazolyl peptides such as micrococcin which is known to inhibit protein synthesis by acting directly on the ribosome. Despite this similarity GE2270 A showed functional analogy to kirromycin-like antibiotics and pulvomycin, as its molecular target was found to be elongation factor Tu (EF-Tu). GE2270 A is active against Gram-positive microorganism and anaerobes and differs from the other EF-Tu inhibitors in its spectrum of antimicrobial activity.
一种新型抗生素GE2270 A是从玫瑰扁平双孢菌的发酵液中分离出来的。发现该产物能抑制细菌蛋白质合成。结构特征表明GE2270 A与噻唑基肽(如微球菌素)有相似之处,已知微球菌素通过直接作用于核糖体来抑制蛋白质合成。尽管有这种相似性,但GE2270 A在功能上类似于奇霉素类抗生素和普尔沃霉素,因为其分子靶点是延伸因子Tu(EF-Tu)。GE2270 A对革兰氏阳性微生物和厌氧菌有活性,并且在抗菌活性谱方面与其他EF-Tu抑制剂不同。